dhealthIQ is a digital therapeutics (‘DTx’) company, enabling healthcare providers to treat and manage chronic cardiometabolic diseases based on evidence-based and personalized interventions directly to the patient. Their researchers and clinicians work side-by-side with software engineers and data scientists to create the next generation of therapeutics. Their therapies, through the balance of human driven support and AI technology, have a strong focus on combining pharmaceutical, lifestyle and behavioral components within the treatment process.